NO20002545L - Anestetisk formulering - Google Patents

Anestetisk formulering

Info

Publication number
NO20002545L
NO20002545L NO20002545A NO20002545A NO20002545L NO 20002545 L NO20002545 L NO 20002545L NO 20002545 A NO20002545 A NO 20002545A NO 20002545 A NO20002545 A NO 20002545A NO 20002545 L NO20002545 L NO 20002545L
Authority
NO
Norway
Prior art keywords
saccharide
amount
additional non
anesthetic agent
anesthetic formulation
Prior art date
Application number
NO20002545A
Other languages
English (en)
Other versions
NO328684B1 (no
NO20002545D0 (no
Inventor
Stephen Brown
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9724506.2A external-priority patent/GB9724506D0/en
Priority claimed from GBGB9818109.2A external-priority patent/GB9818109D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of NO20002545L publication Critical patent/NO20002545L/no
Publication of NO20002545D0 publication Critical patent/NO20002545D0/no
Publication of NO328684B1 publication Critical patent/NO328684B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
NO20002545A 1997-11-19 2000-05-18 Anestetisk formulering NO328684B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9724506.2A GB9724506D0 (en) 1997-11-19 1997-11-19 Levobupivacaine and its use
GBGB9818109.2A GB9818109D0 (en) 1998-08-19 1998-08-19 Anaesthetic Formulation
PCT/GB1998/003479 WO1999025349A1 (en) 1997-11-19 1998-11-19 Anaesthetic formulation

Publications (3)

Publication Number Publication Date
NO20002545L true NO20002545L (no) 2000-05-18
NO20002545D0 NO20002545D0 (no) 2000-05-18
NO328684B1 NO328684B1 (no) 2010-04-26

Family

ID=26312628

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002545A NO328684B1 (no) 1997-11-19 2000-05-18 Anestetisk formulering

Country Status (17)

Country Link
US (1) US5932597A (no)
EP (1) EP1032390B1 (no)
JP (1) JP2001522888A (no)
KR (1) KR100695588B1 (no)
CN (1) CN1131033C (no)
AT (1) ATE253913T1 (no)
AU (1) AU740914B2 (no)
BR (1) BR9814883A (no)
CA (1) CA2308495C (no)
DE (1) DE69819770T2 (no)
DK (1) DK1032390T3 (no)
ES (1) ES2209217T3 (no)
HU (1) HU228143B1 (no)
IL (1) IL135922A0 (no)
NO (1) NO328684B1 (no)
PT (1) PT1032390E (no)
WO (1) WO1999025349A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824161D0 (en) * 1998-11-04 1998-12-30 Darwin Discovery Ltd Drug formulation
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP1575569B1 (en) 2002-12-13 2010-09-29 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
RS52198B (sr) 2004-09-17 2012-10-31 Durect Corporation Rastvor lokalnog anestetika koji sadrži saib sa održivim delovanjem
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
ES2388355T3 (es) 2006-11-03 2012-10-11 Durect Corporation Sistemas de suministro transdémico que comprenden bupivacaína
EP2219622A1 (en) * 2007-12-06 2010-08-25 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
EP2882745A2 (en) * 2012-05-10 2015-06-17 Cellixbio Private Limited Compositions and methods for the treatment of local pain
JP2016515523A (ja) 2013-03-15 2016-05-30 デュレクト コーポレーション 溶解変動性を低減させるためのレオロジー改質剤を有する組成物
WO2017009862A1 (en) * 2015-07-13 2017-01-19 Neon Laboratories Limited Hyperbaric solution injection of levobupivacaine hydrochloride comprising levobupivacaine hydrochloride
MY205229A (en) 2016-07-06 2024-10-08 Durect Corp Oral dosage form with drug composition, barrier layer and drug layer
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods
WO2025175174A1 (en) * 2024-02-14 2025-08-21 The Children's Medical Center Corporation 2'-6'-pipecoloxylidide as a sensory-selective anesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8802564D0 (sv) * 1988-07-08 1988-07-08 Astra Ab New synergistic preparations and a new method of alleviation of pain
HK1006420A1 (en) * 1993-10-13 1999-02-26 Chiroscience Limited Analgesic agent and its use
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use

Also Published As

Publication number Publication date
CN1279607A (zh) 2001-01-10
WO1999025349A1 (en) 1999-05-27
EP1032390A1 (en) 2000-09-06
DE69819770T2 (de) 2004-09-23
DK1032390T3 (da) 2004-03-15
KR100695588B1 (ko) 2007-03-14
BR9814883A (pt) 2000-10-03
HUP0004665A2 (hu) 2001-04-28
JP2001522888A (ja) 2001-11-20
ATE253913T1 (de) 2003-11-15
CA2308495A1 (en) 1999-05-27
NO328684B1 (no) 2010-04-26
HK1026848A1 (en) 2000-12-29
IL135922A0 (en) 2001-05-20
CN1131033C (zh) 2003-12-17
NO20002545D0 (no) 2000-05-18
PT1032390E (pt) 2004-04-30
US5932597A (en) 1999-08-03
HUP0004665A3 (en) 2004-05-28
AU740914B2 (en) 2001-11-15
AU1168499A (en) 1999-06-07
KR20010032241A (ko) 2001-04-16
ES2209217T3 (es) 2004-06-16
CA2308495C (en) 2009-01-06
HU228143B1 (en) 2012-12-28
EP1032390B1 (en) 2003-11-12
DE69819770D1 (de) 2003-12-18

Similar Documents

Publication Publication Date Title
DK1032390T3 (da) Anæstetisk formulering
BR0207420A (pt) Processo e composições para desinfecção de superfìcies duras
BR0108828A (pt) Formulação de carboidrato (adjuvante pré-biótico) para aperfeiçoamento de resposta imuno
BR0214264A (pt) Composição, processo de preparação da composição e seus usos
PL363452A1 (en) 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
ATE179884T1 (de) Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen
ATE367097T1 (de) Verwendung von füllstoffe als sättigungsmittel
DE69931766D1 (de) Antitumorale mittel
ES2133426T3 (es) Combinaciones de productos activos fungicidas.
EE03235B1 (et) Emulsioonvorm, selle valmistamise protsess ja kasutamine
AU2003298179A1 (en) Lens care composition and method
JP2001522888A5 (no)
ATE273033T1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung
RU2004102395A (ru) Жидкая композиция, включающая сложный эфир полиоксиэтиленсорбита и жирной кислоты
BR0209206A (pt) Clatrato de hidrato de azitromicina com 1,2-propileno glicol, processo para a sua preparação e composição farmacêutica compreendendo o mesmo
DK0666739T3 (da) Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
ATE238803T1 (de) Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel
BR9811843A (pt) Sistema de agente de consevação para produtos de tratamento corporal
DE69326840D1 (de) Ophtalmische Zusammensetzungen enthaltenden Emedastine und ihre Verwendungzur Behandlung von allergischer Konjunktivitis
DK0647129T3 (da) Præparat til topisk anvendelse
ATE333877T1 (de) Amlopidinbezylat-tabletten mit verbesserter stabilität
ES2189886T3 (es) Composicion farmaceutica para aplicacion topica.
ES2148315T3 (es) Composicion espesa fluidizable mediante esfuerzo cortante.
DE60207824D1 (de) Cytidin-diphosphocholin gegen diabetische neuropathie
PT1448219E (pt) Agente antiglaucomatoso e sua utilizacao

Legal Events

Date Code Title Description
MK1K Patent expired